Parkev Tatevosian, CFA 对 $LLY 的判断变化

频道资料 →频道引用的来源:Barclays analyst Dan Levy、Meta management and CEO Mark Zuckerberg、Nike management共 3 条

Parkev Tatevosian, CFA 自 2026-09-26 起在 3 个视频里谈过 $LLY,最近一次(2026-11-10)为看涨。

2026-11-10看涨
《My Forever Portfolio: 4 Spectacular Stocks You Can Buy Now and Never Sell》
AI 摘要 · 礼来是一只可以永久买入并持有的推荐标的,因为其数十年来接连不断的成功——不只是减肥药——使当前的成功并非昙花一现;股价为1,366美元,而他给出的估值为1,662美元,他持有该股并希望继续加仓。

你在这里看到的是我的估值,以及我为我要提到的第一只股票所做的现金流折现模型。这只股票你现在就可以买入并永久持有,它就是Eli Lilly。

What you see here is my valuation, and my discounted cash flow model for the first stock I'm going to mention that you can buy now and hold forever, which is Eli Lilly.

Eli Lilly是一家制药公司,在研发治疗药物方面拥有数十年经验,这些药物带来了数十亿美元的销售额和利润。目前,该公司正受益于其在减肥治疗领域最近取得的成功,但这家公司有着一个成功接着一个成功的历史。

Eli Lilly is a pharmaceutical company with decades of experience in researching and developing treatments that generate billions of dollars in sales and profits. Currently, the company is benefiting from its recent success in weight loss treatments, but the company has a history of one success after another.

2026-09-28看涨
《3 Undervalued Healthcare Stocks Invstors Can Buy Right Now》
AI 摘要 · LLY 目前被低估(公允价值 1,494 美元,现价 1,153 美元),受减肥药强劲势头与自由现金流增长推动,预计 12-18 个月内上涨约 30%。

我们将从一家市值约一万亿美元的公司,走向一家市值超过一万亿美元的公司,这家公司就是Eli Lilly。我无需解释Eli Lilly受益于什么;这一积极势头当然来自减肥治疗药物所创造的销售热潮,这让我想起Nvidia和Micron等人工智能公司的销售热潮。

We will move from a company with a market value of about one billion dollars to a company with a market value of more than one trillion dollars, which is Eli Lilly. I don't need to explain what Eli Lilly benefits from; the positive momentum is of course the weight loss treatments that have created a sales boom, which reminds me of the sales boom of artificial intelligence companies like Nvidia and Micron.

2026-09-26看涨
Eli Lilly Might Be the Next Stock I Buy | LLY Stock Analysis
订阅或试用后可见这一步的正文
更早的 1 条正文需要订阅
最近 2 条的正文公开可读。更早的条目保留日期与方向,正文随订阅解锁。
订阅后阅读全部 1 条更早的观点